Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 584-87-2 | MDL No. : | MFCD00016595 |
Formula : | C8H6O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NXZBZWZORYEIJL-UHFFFAOYSA-N |
M.W : | 166.13 | Pubchem ID : | 271761 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 40.81 |
TPSA : | 74.6 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.02 cm/s |
Log Po/w (iLOGP) : | 0.54 |
Log Po/w (XLOGP3) : | 0.42 |
Log Po/w (WLOGP) : | 0.9 |
Log Po/w (MLOGP) : | 0.38 |
Log Po/w (SILICOS-IT) : | 0.89 |
Consensus Log Po/w : | 0.63 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.37 |
Solubility : | 7.04 mg/ml ; 0.0424 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.55 |
Solubility : | 4.64 mg/ml ; 0.0279 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.14 |
Solubility : | 12.1 mg/ml ; 0.0729 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.16 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H317-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With methanol In hexane; toluene at 0 - 20℃; for 1 h; | Example 7b: Preparation of 3-(2,2-Dibromovinyl)-4-hydroxybenzoic acid methyl esterTo a solution of 3-formyl-4-hydroxybenzoic acid (1.00 g, 5.9 mmol) in toluene-MeOH (2:1, 30 mL) was added (trirnethylsilyl)diazomethane (2.0 M solution in hexane, 16 mL, 32 mmol) at 0 0C, and the mixture was stirred for 1 h at rt. After evaporating the solvent, the resulting residue was filtrated through a plug of silica gel eluting with 15percent EtOAc in hexane to afford 3-formyl-4-hydroxybenzoate as a colorless solid (1.06 g, 99percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | Stage #1: With copper(I) oxide In trifluoroacetic acid for 5 h; Reflux Stage #2: With hydrogenchloride In water at 20℃; for 1 h; |
General procedure: To a solution of substrates (1a–1q, 0.15 mmol) in trifluoroacetic acid (5 ml), hexamethylenetetramine (0.3 mmol) and cuprous oxide (0.15 mmol) were added. The reaction mixture was refluxed for about 5 h, cooled to room temperature, followed by addition of hydrochloric acid (3 N, 5 ml). After stirring for another 1 h, the solution was concentrated under reduced pressure. The products were purified by silica gel column chromatography (200–300 mesh). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23% | With hydrogenchloride; sodium hydroxide; sodium hydrogensulfite In chloroform; water | EXAMPLE 36 3-Formyl-4-hydroxybenzoic acid 140 g (1.01 mol) of 4-hydroxybenzoic acid were added to a hot solution of 250 g (6.25 mol) of sodium hydroxide in 500 mL H2 O. 150 mL of CHCl3 were cautiously added to the hot solution, and after the foaming had ceased, the reaction mixture was stirred overnight at room temperature. The reaction mixture was then diluted to 4 L with H2 O, acidified to pH 1 by addition of about 300 mL of concentrated HCl, and extracted two times with 2 L and then three times with 1 L ethyl ether. The ether extracts were combined and a solution of 750 g sodium bisulfite in 3 L H2 O was added. This mixture was stirred thoroughly for 2 minutes, then the layers were separated and the aqueous layer was extracted two times with 500 ml ethyl ether. The aqueous layer was acidified by slow addition of a solution of 230 mL concentrated H2 SO4 in 230 mL H2 O. Vigorous SO2 evolution was noted. The solution was then heated on a steam bath, and a stream of N2 was blown through the hot solution for about 15 minutes until a large amount of crystals formed. The mixture was allowed to stand at room temperature overnight, then cooled to -10° C. for 1/20 hour, then filtered. The crystals were washed two times with H2 O and then dried under vacuum to yield 38.46 g of the title product as a tan powder. 23percent yield. 1 H NMR (300 m Hz, DMSO-d6): δ10.3 (s, 1H). MS (Cl, NH3): 183 M+17, 166 (M+), 165 Base. |
[ 619-12-5 ]
4-Formyl-3-hydroxybenzoic acid
Similarity: 0.98
[ 499-76-3 ]
4-Hydroxy-3-methylbenzoic acid
Similarity: 0.98
[ 586-30-1 ]
3-Hydroxy-4-methylbenzoic acid
Similarity: 0.95
[ 619-12-5 ]
4-Formyl-3-hydroxybenzoic acid
Similarity: 0.98
[ 613-84-3 ]
2-Hydroxy-5-methylbenzaldehyde
Similarity: 0.88
[ 824-42-0 ]
2-Hydroxy-3-methylbenzaldehyde
Similarity: 0.85
[ 619-12-5 ]
4-Formyl-3-hydroxybenzoic acid
Similarity: 0.98
[ 499-76-3 ]
4-Hydroxy-3-methylbenzoic acid
Similarity: 0.98
[ 4919-37-3 ]
4-Hydroxy-3,5-dimethylbenzoic acid
Similarity: 0.95
[ 586-30-1 ]
3-Hydroxy-4-methylbenzoic acid
Similarity: 0.95